We investigated the role of apoptosis in the development of B cell memory by analyzing the (p-azophenylarsonate) Ars response in a line of A strain mice in which expression of human Bcl-2 was enforced in the B cell compartment. 
INTRODUCTION
Upon activation by antigen, mature B-lymphocytes migrate to the primary follicle and establish distinct microenvironments known as germinal centers (GCs) . Once located in the GC, B cells undergo a series of differentiation events. One of these events is the activation of a somatic hypermutation mechanism, which rapidly introduces point mutations into Ig variable (V) regions (Tsiagbe et al., 1996) . Although not completely random, somatic hypermutation can result in various V region phenotypes. For instance, some mutations may disrupt the structural integrity of the V region leading to a loss of function (Manser et al., 1987a; Schlomchik et al., 1989) , whereas others can result in an increase in antibody affinity (Berek et al., 1987; Sharon et al., 1989; Weiss et al., 1990 ). These high affinity variants provide the substrate for serum antibody affinity maturation. In addition, certain mutations can often fortuitously generate V regions with an autoreactive phenotype (Casson and Manser, 1995; Hande and Manser 1997) .
B cells in the GC have also been demonstrated to exhibit a high incidence of apoptosis (MacLennan, To whom correspondence and proofs should be addressed. Phone number: (215)-503-4543; fax number: (215)-923-4153. 224 EVANGELIA NOTIDIS et al. 1994 ) which is believed to mediate the disappearance of low affinity V region mutants, autoreactive mutants, or both. The susceptibility of GC B cells to apoptosis can be attributed to factors such as the absence of the anti-apoptotic protein Bcl-2 (Martinez-Valdez et al., 1996) and high expression of Fas (CD95) (Tsiagbe et al., 1996) . Evidence to support the sensitivity of GC B cells to apoptotic signals has also been demonstrated in studies where GC B cells interact with high levels of cognate soluble antigen in situ (Pulendran et al., 1995; Shokat and Goodnow, 1995; Han et al., 1995) ; a situation argued to mimic a form of tolerance induction in vivo.
During the immune response to the hapten Ars in A/J mice, there is the predominance of a particular clonotype termed the canonical clonotype (Manser et al., 1987b; Rathbun et al., 1989; Wysocki et al., 1987) . Canonical antibodies are composed of specific heavy and light chain V regions that prior to somatic mutation, differ only at their VH-D and D-J H segment junctions.
Previous in vitro mutagenesis studies of canonical monoclonal antibodies (mAbs) have illustrated that certain mutations in the CDRs often result in simultaneous increases in the affinity for foreign (Ars) and self (DNA) antigen (Casson and Manser, 1995; Hande and Manser 1997) . However, previous in vivo data revealed that such "dual" reactive canonical antibodies are absent from the Ars-induced memory B cell compartment (Naparstek et al., 1986) . Suggesting therefore, that dual reactive mutants were absent from the memory compartment of normal healthy individuals due to the action of a peripheral tolerance checkpoint. In order to test this hypothesis we have studied the immune response to Ars in A strain mice which constitutively expressed Bcl-2 in the B cell compartment.
Initial analyses of the Ars response in A.Bcl-2 mice indicated that most aspects of this response were not overtly altered. Participation of canonical anti-Ars clonotypes in the immune response and somatic mutation of canonical antibodies appeared comparable to normal A strain mice (Hande et al., 1998) . However, whereas dual reactive hybridomas are not isolated from secondary and tertiary fusions from A strain mice, such hybridomas made up approximately 25% of the canonical expressing secondary and tertiary hybridomas isolated from A.Bcl-2 mice (Hande et al., 1998) . These data suggested that altering apoptosis obstructs negative selection of dual reactive clones in the periphery.
B cell tolerance has also been studied in other transgenic mouse lines in which Bcl-2 expression is enforced in the B cell compartment. In particular, a recent study by Kuo et al., (1999) suggests that altering Bcl-2 expression affects central tolerance but does not affect peripheral tolerance. Specifically, dual reactive anti-DNA, anti-phosphorylcholine (PC) B cells could be recovered by hybridoma technology late in the primary response but did not appear in the anti-PC memory B cell compartment (Kuo et al., 1999) . Additional studies from the same group also argue that although Bcl-2 does not affect the frequency of somatic mutation, it impairs the clustering of mutations to "hot spot" motifs (Kuo et al., 1997) . In addition to Bcl-2 transgenics, maturation of the B cell response has also been investigated in mice over-expressing the anti-apoptotic protein Bcl-x L in B cells (Fang et al., 1996) . Studies of these transgenic mice demonstrated that over-expression of Bcl-x L alters affinity maturation allowing low affinity B cells to participate in the response (Takahashi et al., 1999 To obtain A strain mice with constitutive B cell expression of Bcl-2, the M23 Bcl-2 transgenic mouse line (Smith et al., 1994) was backcrossed to the A/J mouse strain for 4-6 generations. The M23 transgene is a reconstruction of the t(14;18)(q32;q21) translocation observed in B cell lymphomas and has a central region of human Bcl-2 cDNA that contains the exon II exon III juncture (McDonnell et al., 1989) . The expression of the human Bcl-2-Ig fusion "minigene" allows the expression of transgene encoded Bcl-2 protein to be unambiguously distinguished from endogenous mouse Bcl-2 expression. To evaluate this expression, immunohistochemical staining was performed on frozen spleen sections from 5-week-old naive A.Bcl-2 mice, using a mouse IgG1 mAb that recognizes human Bcl-2 protein followed by a goat anti-mouse IgG mAb.
Transgenic Bcl-2 expression was predominantly localized in follicles, including GCs, with a more scattered expression in the PALS and red pulp ( Figure 1A ). As expected, transgene negative littermates displayed only occasional IgG positive B cells ( Figure 1B (Hande et al., 1998) . The vast majority of the canonical hybridomas isolated expressed mAbs that were class-switched, had undergone extensive somatic mutation and were Ars binding. In addition, data from this analysis demonstrated that altering apoptotic pathways regulated by Bcl-2 allowed for the entry of dual reactive B cells into the memory compartment. Sequence analysis of the Ars-DNA binding V regions that were isolated revealed that the overall pattern of somatic mutation did not differ from that observed in the V regions isolated from the memory compartment of normal A strain mice (Manser, 1991) . Several of these dual 226 reactive mAbs also displayed relative DNA binding that was as good as or better than the autoantibody 3H9 which was isolated from a diseased MRL lpr/lpr mouse (Shlomchik et al., 1987) . Thus, enforced Bcl-2 expression in the B cell compartment allowed for the expansion of canonical dual reactive B cells. Consequently, we decided to investigate whether these B cells produced any serum antibody.
We primed both A.Bcl-2 mice and transgene negative control littermates with Ars-KLH in CFA. The mice were then bled, boosted with Ars-KLH in PBS and bled again following secondary and tertiary immunizations. Bulk anti-ssDNA, anti-dsDNA, and anti-Ars antibody titers were then determined and compared between A.Bcl-2 mice ( Figure 2A -2F and in our previous analysis (Hande et al., 1998) , the serum antibody levels in both groups are comparable, with a slight increase in the level of anti-ssDNA and anti-dsDNA antibodies in the A.
Bcl-2 mice during tertiary immune responses ( Figure 2C ). This increase may be attributed to the overall increase in serum Ig, which is observed in these mice during a tertiary immune response ( Figure 3B ). This is in accord with previous studies of Bcl-2 transgenic mice, which demonstrated that they have a prolonged AFC response (Smith et al., 1994) and that they display mild hypergammaglobulinemia with age (McDonnell et al., 1989) . Previous studies on autoreactive Ig transgenic mouse models have demonstrated that although B cells with a low affinity for DNA persist in the periphery and can be rescued as hybridomas, they do not produce serum antibody (Erikson et al., 1991 Figure 5 , all of the hybridomas analyzed showed evidence of somatic mutation in their V H genes. One of the hybridomas, 10-5-A9, also possesses affinity-enhancing mutations at positions 58 and 59 in CDR2. Specifically, the V H gene it expresses contains the Thr58-lie and Lys59-Thr mutations that have previously been shown to result in an increase in affinity for Ars (Sharon et al., 1989) . Bcl-2 mice, another sample of the canonical Ars+DNA hybridomas were selected for fluorescence quenching analysis of their expressed mAbs (Table I ). As shown in Table I , all of the K a values obtained for these mAbs were greater than 106 M-1. The average affinity for these antibodies was 2.9 106 M-1, which is approximately a 10-fold increase over the affinity characteristic of unmutated canonical V regions, such as the monoclonal antibody, 36-65. Such an increase in affinity is characteristic of affinity matured, canonical V regions isolated from Ars-immunized A/J mice (Manser, 1991 (Smith et al., 1996; Rogozin and Kolchanov 1992; Betz et al., 1993; Shapiro et al., 1999 Recent reports have identified a number of tri-and tetra nucleotide consensus sequences that appear to be targeted for mutation (Smith et al., 1996) . We examined the mutations clustered in the tri-nucleotide "hot spots" AGC, TAC, GCT and GTA (Table II) (Smith et al., 1996) . In addition, we also examined the level of mutational clustering found at the mutational hot spot designated by the motif purine/G/pyrimidine/A or T or RGYW (Rogozin and Kolchanov 1992) (Table II) .
The average percentage of mutations clustered at the tri-nucleotide hot spots AGC/TAC/GCT/GTA for A. Bcl-2 mice was 26%, compared to normal A strain mice which had an average percentage of 22%. Thus, the percentages of mutations clustered at these mutational "hot spot" motifs between the two groups were comparable (Table II) . The same conclusion can also be drawn from the comparison made at the mutational hot spot RGYW where the average percent of clustering for the V genes obtained from A.Bcl-2 mice was 37%, compared to controls, which was 32%. The mutational frequencies between the two groups were also comparable, where V H genes from A/J mice had a mutation frequency of 2.0% and those from A.Bcl-2 mice had a frequency of 1.9%. Therefore, enforced expression of Bcl-2 in A.Bcl-2 mice does not overtly alter the frequency of somatic mutation or "targeting" of these mutations to hot spots.
DISCUSSION
Preliminary studies using A.Bcl-2 mice indicated that most aspects of the Ars immune response in these mice were comparable to those in non-transgenic A strain mice. Specifically, there was normal participation of the predominant canonical clonotype of the Ars response, comparable levels of anti-Ars serum antibodies, and somatic hypermutation took place in canonical antibody expressing GCs (Hande at al., 1998) . Overall, our data were in accord with previous findings, which suggested that many of the antigen-driven stages of T cell dependent B cell differentiation are unaffected in Bcl-2 transgenic mice (Smith et al., 1994) .
However, unlike normal A strain mice which lack Ars-DNA dual specific antibody expressing B cells in their memory compartment, such B cells were readily detected in the memory compartment of A.Bcl-2 mice (Hande at al., 1998) . These findings stand in contrast to those obtained from studies of the anti-PC response in Etbcl-2-22 transgenic BALB/c mice. Kuo, et al., (1999) isolated PC-DNA dual reactive B cell hybridomas during the late primary response to PC, but failed to do so in the secondary response. However, unlike the dual reactive hybridomas we had previously isolated, those isolated by Kuo, et al., (1999) were encoded by unmutated V H genes; suggesting that expression of Bcl-2 in these transgenic mice allows dual reactive B cells to escape central tolerance in the bone marrow. Conversely, our studies indicated that the over-expression of Bcl-2 resulted in dual reactive B cells escaping some form of peripheral tolerance, since all of the hybridomas isolated had evidence of somatic hypermutation (Hande at al., 1998) . Although dual reactive hybridomas were easily isolated from Ars-immunized A. Bcl-2 mice, there were no significant elevations of serum anti-DNA antibodies in these mice. In this case our results are consistent with those of the anti-PC response in Egbcl-2-22 transgenic BALB/c mice, which reported that titers of serum anti-DNA antibodies in these mice did not rise following primary or secondary PC immunizations (Kuo at al., 1990) . Erikson et al., (1991) have also reported that in mice transgenic for the 3H9 heavy chain, transgene expressing B cells with a low affinity for DNA are resident in the periphery and can be isolated as hybridomas, but produce undetectable levels of serum antibody. Further analysis of the same transgene expressing B cells, demonstrated that they were phenotypically distinct from non-transgenic B cells and that they were functionally compromised (Nguyen et al., 1997 (Cooke et al., 1994) . Particularly, it has been demonstrated that anergic B cells exhibit a proximal block in the sIg signaling pathway which prevents activation of receptor-associated tyrosine kinases in response to soluble antigen (Cooke at al., 1994) . Whether dual -reactive B cells in A.Bcl-2 mice are anergic due to a B cell receptor signaling defect will require further study.
The anti-Ars serum antibodies that were elicited in A.Bcl-2 mice also exhibited evidence of normal affinity maturation. This is in accordance with earlier studies of the (4-hydroxy-3-nitrophenyl)acetyl (NP) response in Egbcl-2-22 C57B1/6 transgenic mice, which demonstrated that affinity maturation to the hapten NP was not affected by over-expression of Bcl-2 (Smith et al., 1994) . In contrast, studies of the NP response in Bcl-x L transgenic mice have shown that over-expression of Bcl-x L influences affinity maturation (Takahashi et al., 1999) . In these studies it was observed that low affinity anti-NP clonotypes predominantly participated in the anti-NP response of Bcl-x L mice whereas these clonotypes were minor participants in the NP response of control mice.
The differences in the observed effect of enforced Bcl-2 and Bcl-xLexpression may be attributed to the unique functions of these two different anti-apoptotic proteins. Although the proteins are members of the same family, they appear to function independently of one another and at different stages of B cell development. For example, GC B cells have been demonstrated to down regulate Bcl-2 expression while Bcl-x L has been shown to be expressed in the centrocyte subset of these B cells (Tuscano et al., 1996) . If positive and negative selection of antibody V region mutants take place at distinct stages of the GC reac- (Hande et al., 1998) . Antibodies were elaborated using peroxidase-conjugated goat anti-mouse IgG (Jackson Immunoresearch, Inc. West Grove, PA) followed by o-phenylenediamine (Sigma Chemical Co. St. Louis MO). Affinity maturation of serum antibodies was determined by an altered ligand density ELISA, using two different coupling ratios of Ars to BSA. The bound antibodies were elaborated with a rat anti-mouse kappa antibody followed by Streptavidin-alkaline phosphatase (Southern Biotechnology Associates, Birmingham, AL).
Immunohistochemistry
Spleens were removed, flash frozen, and sectioned as previously described (Hande et al., 1998) . Frozen sections were thawed, rehydrated and treated as before. To determine Bcl-2 transgene expression, sections were incubated with a mouse anti-human Bcl-2 antibody (Genosys Biotechnologies, The Woodlands, TX), which was then detected with biotinylated goat F(ab')2 anti-mouse IgG (Southern Biotechnology Associates, Inc. Birmingham, AL). The slides were incubated with the antibodies for one hour. The slides were washed in TBS-BSA and then incubated with Streptavidin-Alkaline Phosphatase (AP) (Southern Biotechnology Associates, Inc. Birmingham, AL) for one hour. Germinal centers were identified with peanut agglutinin (PNA) coupled to horseradish peroxidase (HRP) (E-Y Laboratories, San Mateo, CA). Bound AP and HRP activities were visualized using Napthol AS-MX/Fast Blue BB Base and 3-aminoethylcarbazole, respectively.
Determination of mAb Affinity
The affinities of purified Ars mAbs were determined by fluorescence quenching using Ars-N-acetyl-L-tyrosine as described before (Manser 1989) . Ars affinities were calculated using a curve-fitting program provided by Jackie Sharon (Boston University School of Medicine, Boston, MA) as described previously (Rothstein and Gefter, 1983) .
Reverse Transcriptase-PCR and Nucleotide Sequencing Total RNA was made from hybridomas as previously described (Manser, 1989) and then subjected to reverse transcriptase-PCR. V H and V: PCR amplification was done using primers described previously (Hande et al., 1998) . The RT-PCR products were purified from agarose gels using the Qiaex II Gel Extraction Kit (Qiagen, Chatsworth, CA) according to the manufacturer's instructions and were sequenced using the "fmol" sequencing kit (Promega Biotech Corp, Madison, WI).
